Geoffrey Dada: Chief Executive Officer of Alpha Therapeutics and a member of the company’s board of directors. He joined Alpha in 2018, bringing more than 15 years of business management experience to his role with the company.
Geoffrey Dada manages corporate direction facilitating company activity in consulting, sales, marketing, alliances and channels, and support.Geoffrey Dada graduated from Manhattan College in 2004 earning his bachelor’s degree in corporate communication.
Previously, Dada served as chief executive officer, and president of HR Base Camp, where his focus on operational efficiency, and execution led to significant company growth. Prior to that, he spent 3 years at Guaranteed Rate as Senior VP.
Tyler Southwell: Chief Medical Officer of Alpha Therapeutics and member of the company’s board of directors, oversees global clinical development and regulatory initiatives for Alpha. Dr. Southwell, who brings more than 17 years of clinical experience to the organization, has an exceptional understanding of how Cannabidiol products work and which patients can greatly improve their quality of life from the regular use of CBD products.
Dr Southwell operates his private practice in Paradise Valley, Arizona, serving his patients as a primary caregiver and helping them fully understand the treatment options available to them. Dr. Southwell makes it a point to establish clear communication between patients and caregivers, which is crucial to treatment effectiveness and truly improving the lives of patients dealing with chronic pain and more. Dr. Southwell’s education and experience include:
Wayne State University School of Medicine in Detroit, Michigan.
University of Toledo, Surgery/Urology Residency
University of Michigan, Family Medicine Residency